Amelioration of Amyloid‐β Induced Alzheimer's Disease by Bacopa monnieri through Modulation of Mitochondrial Dysfunction and GSK‐3β/Wnt/β‐Catenin Signaling
The DOI matches its Crossref record; 62 of the 65 references it cites were found in a registry or an index.
Abstract
Background: Alzheimer's disease (AD) is the most prevalent dementia, affecting a large number of populations. Despite being under scrutiny for decades, an effective therapeutic option is still not available. Methods and results: This study explores the therapeutic role of a nootropic herb Bacopa monnieri (BM) in AD‐like pathological conditions produced by injecting preformed amyloid‐β 42 (Aβ 42 ) fibril bilaterally into hippocampus of Wistar rats, and ethanolic extract of BM is orally administered for 4 weeks. Assessment of behavioral changes reveals that BM treatment ameliorates Aβ 42 ‐induced cognitive impairment and compromised explorative behavior. Supplementation of BM also reduces oxidative stress biomarkers, proinflammatory cytokines, and cholinesterase activity in the AD rats. Additionally, BM treatment restores Bcl‐2‐associated X protein (Bax)/ B‐cell lymphoma 2 (Bcl‐2) imbalance, increases neurotrophic factors expression, and prevents neurodegeneration validated by quantifying Nissl‐positive hippocampal neurons. Interestingly, BM administration eliminates amyloid plaques in the hippocampal region and normalizes the Aβ 42 ‐induced increase in phospho‐tau and total tau expression. Mechanistic investigations reveal that BM interacts with glycogen synthase kinase (GSK‐3β) and restores Wnt/β‐catenin signaling. Conclusion: BM has been used in diet as a nootropic herb for several centuries. This study highlights the anti‐Alzheimer activity of BM from the behavioral to the molecular level by modulating mitochondrial dysfunction, and GSK‐3β mediates the Wnt/β‐catenin signaling pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bacopa monnieri extract (40–80 mg/kg) reduced Alzheimer’s-like symptoms in Aβ42-injected rats by improving cognitive function, preserving hippocampal neurons, modulating the GSK-3β/Wnt/β-catenin pathway, and significantly decreasing AChE activity at 80 mg/kg [78].”
From Cholinesterase Inhibitors from Plants and Their Potential in Alzheimer’s Treatment: Systematic Review (2025) · cites this paper as [78]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Determination of malonaldehyde precursor in tissues by thiobarbituric acid test
Uchiyama, M., & Mihara, M. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90342-1 · Cited by 5,188
AChE-stained horizontal sections of the rat brain in stereotaxic coordinates
Paxinos, G., Watson, C. R. R., & Emson, P. C. (1980) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(80)90021-7 · Cited by 4,497
Jollow, D. J., Mitchell, J. R., Zampaglione, N., & Gillette, J. R. (2008) · Pharmacology · doi:10.1159/000136485 · Cited by 3,285
Gabedit—A graphical user interface for computational chemistry softwares
Allouche, A. (2011) · Journal of Computational Chemistry · doi:10.1002/jcc.21600 · Cited by 2,460
2022 Alzheimer's disease facts and figures
(2022) · Alzheimer's & Dementia · doi:10.1002/alz.12638 · Cited by 2,341
CRC handbook of methods for oxygen radical research
Bogomolets, B. B. (1985) · Experimental Gerontology · doi:10.1016/0531-5565(85)90021-x · Cited by 1,546
Mechanisms of cytochrome c release from mitochondria
Garrido, C., Galluzzi, L., Brunet, M., Puig, P. E., Didelot, C., & Kroemer, G. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401950 · Cited by 1,390
Cold Spring Harbor Perspectives in Biology
(2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect_biol/ · Cited by 942
Praticò, D., Uryu, K., Leight, S., Trojanoswki, J. Q., & Lee, V. M.-Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04183.2001 · Cited by 777
Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease
Misrani, A., Tabassum, S., & Yang, L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.617588 · Cited by 654
Amyloid-β-independent regulators of tau pathology in Alzheimer disease
van der Kant, R., Goldstein, L. S. B., & Ossenkoppele, R. (2020) · Nature reviews. Neuroscience · doi:10.1038/s41583-019-0240-3 · Cited by 580
Oxidative stress in Alzheimer disease
Gella, A., & Durany, N. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.1.7402 · Cited by 459
The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease
Josiane, Tatiani, Francielle, Michelle, & Alexandra (2015) · Aging and disease · doi:10.14336/ad.2015.0825 · Cited by 407
Caricasole, A., Copani, A., Caraci, F., Aronica, E., Rozemuller, A. J., Caruso, A., Storto, M., Gaviraghi, G., Terstappen, G. C., & Nicoletti, F. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1381-04.2004 · Cited by 398
Phosphorylation of different tau sites during progression of Alzheimer’s disease
Neddens, J., Temmel, M., Flunkert, S., Kerschbaumer, B., Hoeller, C., Loeffler, T., Niederkofler, V., Daum, G., Attems, J., & Hutter-Paier, B. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0557-6 · Cited by 384
Hippocampal atrophy rates in Alzheimer disease: Added value over whole brain volume measures
Henneman, W. J. P., Sluimer, J. D., Barnes, J., van der Flier, W. M., Sluimer, I. C., Fox, N. C., Scheltens, P., Vrenken, H., & Barkhof, F. (2009) · Neurology · doi:10.1212/01.wnl.0000344568.09360.31 · Cited by 350
De Ferrari, G. V., Chacón, M. A., Barría, M. I., Garrido, J. L., Godoy, J. A., Olivares, G., Reyes, A. E., Alvarez, A., Bronfman, M., & Inestrosa, N. C. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001208 · Cited by 332
Assay of superoxide dismutase activity in animal tissues
Nandi, A., & Chatterjee, I. B. (1988) · Journal of Biosciences · doi:10.1007/bf02712155 · Cited by 330
Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement
Stanciu, G. D., Luca, A., Rusu, R. N., Bild, V., Beschea Chiriac, S. I., Solcan, C., Bild, W., & Ababei, D. C. (2019) · Biomolecules · doi:10.3390/biom10010040 · Cited by 297
Cognitive enhancement and neuroprotective effects of Bacopa monnieri in alzheimer’s disease model
Uabundit, N., Wattanathorn, J., Mucimapura, S., & Ingkaninan, K. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.09.056 · Cited by 282
Role of tau protein in Alzheimer’s disease: The prime pathological player
Muralidar, S., Ambi, S. V., Sekaran, S., Thirumalai, D., & Palaniappan, B. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.327 · Cited by 278
Donovan, N. J., Locascio, J. J., Marshall, G. A., Gatchel, J., Hanseeuw, B. J., Rentz, D. M., Johnson, K. A., Sperling, R. A., & Study, F. T. H. A. B. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17040442 · Cited by 272
History and New Developments of Assays for Cholinesterase Activity and Inhibition
Miao, Y., He, N., & Zhu, J.-J. (2010) · Chemical Reviews · doi:10.1021/cr900214c · Cited by 267
Avrahami, L., Farfara, D., Shaham-Kol, M., Vassar, R., Frenkel, D., & Eldar-Finkelman, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.409250 · Cited by 231
Wnt-3a overcomes β-amyloid toxicity in rat hippocampal neurons
Alvarez, A. R., Godoy, J. A., Mullendorff, K., Olivares, G. H., Bronfman, M., & Inestrosa, N. C. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.02.028 · Cited by 213
Limpeanchob, N., Jaipan, S., Rattanakaruna, S., Phrompittayarat, W., & Ingkaninan, K. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.07.039 · Cited by 206
Lithium Improves Hippocampal Neurogenesis, Neuropathology and Cognitive Functions in APP Mutant Mice
Fiorentini, A., Rosi, M. C., Grossi, C., Luccarini, I., & Casamenti, F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014382 · Cited by 175
Increased Dickkopf‐1 expression in transgenic mouse models of neurodegenerative disease
Rosi, M. C., Luccarini, I., Grossi, C., Fiorentini, A., Spillantini, M. G., Prisco, A., Scali, C., Gianfriddo, M., Caricasole, A., Terstappen, G. C., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06566.x · Cited by 171
A simplified model for mitochondrial ATP production
Bertram, R., Gram Pedersen, M., Luciani, D. S., & Sherman, A. (2006) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2006.07.019 · Cited by 168
Case, D. A., Aktulga, H. M., Belfon, K. A. A., Ben‐Shalom, I., Brozell, S. R., Cerutti, D. S., Cheatham, T. E., Cruzeiro, V. W. D., Darden, T., Duke, R. E., et al. (2021) · Open Repository and Bibliography (University of Luxembourg) · Cited by 162
The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain
Nemetchek, M. D., Stierle, A. A., Stierle, D. B., & Lurie, D. I. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.07.073 · Cited by 158
Bacopa monniera extract reduces amyloid levels in PSAPP mice
Holcomb, L. A., Dhanasekaran, M., Hitt, A. R., Young, K. A., Riggs, M., & Manyam, B. V. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9303 · Cited by 156
Bacopa monnieri as an Antioxidant Therapy to Reduce Oxidative Stress in the Aging Brain
Simpson, T. N., Pase, M. P., & Stough, C. K. K. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/615384 · Cited by 133
Sharma, S., Verma, S., Kapoor, M., Saini, A., & Nehru, B. (2016) · Neurological Research · doi:10.1080/01616412.2016.1209337 · Cited by 89
The Role of Wnt Signaling in the Development of Alzheimer’s Disease: A Potential Therapeutic Target?
Wan, W., Xia, S., Kalionis, B., Liu, L., & Li, Y. (2014) · BioMed Research International · doi:10.1155/2014/301575 · Cited by 87
Uddin, M. S., Al Mamun, A., Kabir, M. T., Ashraf, G. M., Bin-Jumah, M. N., & Abdel-Daim, M. M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02116-9 · Cited by 86
Malishev, R., Shaham‐Niv, S., Nandi, S., Kolusheva, S., Gazit, E., & Jelinek, R. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00438 · Cited by 81
Presynaptic protein synthesis required for NT-3-induced long-term synaptic modulation
Je, H. S., Ji, Y., Wang, Y., Yang, F., Wu, W., & Lu, B. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-1 · Cited by 74
Rastogi, M., Ojha, R. P., Prabu, P. C., Devi, B. P., Agrawal, A., & Dubey, G. P. (2012) · Biogerontology · doi:10.1007/s10522-011-9367-y · Cited by 71
Buechling, T., & Boutros, M. (2011) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-385975-4.00008-5 · Cited by 70
Lee, S., Youn, K., Lim, G., Lee, J., & Jun, M. (2018) · Molecules · doi:10.3390/molecules23071509 · Cited by 65
Neuroprotection with Bacopa monnieri–A review of experimental evidence
Shalini, V. T., Sajjanar, N. J., & Sriranjini, J. S. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06236-w · Cited by 65
Ilouz, R., Kowalsman, N., Eisenstein, M., & Eldar-Finkelman, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604633200 · Cited by 62
Ahmad, M. H., Fatima, M., Ali, M., Rizvi, M. M. A., & Mondal, A. C. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108831 · Cited by 61
Self-citationThe Lewy body variant of Alzheimer’s disease: clinical, pathophysiological and conceptual issues
Förstl, H. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/pl00014176 · Cited by 55
Bacopa monnieri reduces Tau aggregation and Tau-mediated toxicity in cells
Dubey, T., Kushwaha, P., Thulasiram, H. V., Chandrashekar, M., & Chinnathambi, S. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123171 · Cited by 55
Singh, M., Murthy, V., & Ramassamy, C. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091729 · Cited by 46
Banerjee, R., Hazra, S., Ghosh, A. K., & Mondal, A. C. (2014) · Psychiatry Investigation · doi:10.4306/pi.2014.11.3.297 · Cited by 46
Self-citationKhanday, M. A., Somarajan, B. I., Mehta, R., & Mallick, B. N. (2016) · eNeuro · doi:10.1523/eneuro.0108-16.2016 · Cited by 41
Khan, M. B., Ahmad, M., Ahmad, S., Ishrat, T., Vaibhav, K., Khuwaja, G., & Islam, F. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9593-5 · Cited by 40
Konar, A., Gautam, A., & Thakur, M. K. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/837012 · Cited by 38
Khalaf, S. S., Hafez, M. M., Mehanna, E. T., Mesbah, N. M., & Abo–Elmatty, D. M. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01616-3 · Cited by 33
Bacopa monnieri inhibits apoptosis and senescence through mitophagy in human astrocytes
Saha, S., Mahapatra, K. K., Mishra, S. R., Mallick, S., Negi, V. D., Sarangi, I., Patil, S., Patra, S. K., & Bhutia, S. K. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111367 · Cited by 33
Suryavanshi, J., Prakash, C., & Sharma, D. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00998-3 · Cited by 27
Sivasangari, K., & Rajan, K. E. (2020) · Antioxidants · doi:10.3390/antiox9121229 · Cited by 26
281006-5 281006-4 Thin Section
Garrido, C. J. (2019) · System for Earth Sample Registration (SESAR) · doi:10.58052/iepgg06yf · Cited by 26
Li, Y., Xing, Y., Shen, Y., Zhao, J., Yue, R., Liu, F., He, W., Wang, R., Shan, L., & Zhang, W. (2016) · Aging · doi:10.18632/aging.100913 · Cited by 23
Nannepaga, J. S., Korivi, M., Tirumanyam, M., Bommavaram, M., & Kuo, C.-H. (2014) · The Chinese Journal of Physiology · doi:10.4077/cjp.2014.bac221 · Cited by 20
Dixit, H., Kumar, C. S., Dasgupta, D., & Gadewal, N. (2021) · Bioinformation · doi:10.6026/97320630017798 · Cited by 8
Dwivedi, S., Nagarajan, R., Hanif, K., Siddiqui, H. H., Nath, C., & Shukla, R. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/262639 · Cited by 2
Research works printed but not linked: 7
- Goswami S., 2011, Int. J. Collab. Res. Intern. Med. Public Health, 3, 285
- Lueptow L. M., 2017, J. Vis. Exp., 2017
- Nunez J., 2008, J. Vis. Exp., 19, 897
- Case D. A., 2018, Amber 2018 Reference Manual
- Tembhre M., 2016, Pharm. Pharmacol. Int. J., 4, 413
- Holmes C., 2017, Dementia, 14, 508
- Wetchateng T., 2015, J. Med. Assoc. Thai., 98, 56
Cited by
Valotto Neto, L. J., Reverete de Araujo, M., Moretti Junior, R. C., Mendes Machado, N., Joshi, R. K., dos Santos Buglio, D., Barbalho Lamas, C., Direito, R., Fornari Laurindo, L., Tanaka, M., et al. (2024) · Antioxidants · doi:10.3390/antiox13040393 · Cited by 146
“However, an imbalance in the generation and neutralization of ROS can accumulate harmful intermediate products and cause OS, leading to brain damage [35,145–150].”
InfluentialUti, D. E., Alum, E. U., Atangwho, I. J., Ugwu, O. P.-C., Egbung, G. E., & Aja, P. M. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03412-z · Cited by 115
Jiang, M., Chi, J., Qiao, Y., Wang, J., Zhang, Z., Liu, J., Sheng, X., & Yuan, L. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107578 · Cited by 72
Faraji, N., Ebadpour, N., Abavisani, M., & Gorji, A. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04462-4 · Cited by 42
ALNasser, M. N., Alboraiy, G. M., Alsowig, E. M., & Alqattan, F. M. (2025) · Brain Sciences · doi:10.3390/brainsci15020215 · Cited by 35
Metadata
- Authors
- Sushma, Sahu, M. R., Murugan, N. A., & Mondal, A. C.
- Affiliations
- Jawaharlal Nehru University (IN)
- Indraprastha Institute of Information Technology Delhi (IN)
- Corresponding author
- Mondal, Amal Chandra
- Venue
- Molecular Nutrition & Food Research
- Publisher
- Wiley
- Published
- 2023-12-24
- Volume
- 68
- Issue
- 13
- Pages
- e2300245-e2300245
- ISSN
- 1613-4125 (ISSN-L)
- 1613-4133
- OpenAlex
- W4390197753
- Cited by
- 17
- References
- 65
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 5
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Nutrition & Food Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Department of Biotechnology, Ministry of Science and Technology, India (BT/PR32907/MED/122/227/2019, BT/PR38493/TRM/120/465/2020)
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, Bacopa monnieri, amyloid-beta 42, GSK3β, Wnt/β-catenin signaling, mitochondrial dysfunction, oxidative stress, neuroinflammation, cholinesterase activity, tau phosphorylation, amyloid plaques, hippocampus, cognitive impairment, neuroprotection
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Alzheimer Disease, Animals, Disease Models, Animal, Hippocampus, Male, Mitochondria, Peptide Fragments, Plant Extracts, Amyloid beta-Peptides, Rats, Wistar, Oxidative Stress, Bacopa, beta Catenin, Rats, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.